Faslodex (fulvestrant)

Faslodex (fulvestrant) is an injectable estrogen receptor antagonist used for the treatment of hormone receptorpositive advanced breast cancer for post-menopausal women whose disease
has progressed following treatment with prior endocrine therapy.